Ameliorated cona-induced hepatitis in the absence of PKC-theta

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Fang, Xianfeng ^a   Wang, Ruiqing ^a   Ma, Jian ^a   Ding, Yan ^a   Shang, Weirong ^b   Sun, Zuoming ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD40 LIGAND; CONCANAVALIN A; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 6; PROTEIN KINASE C THETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; ISOENZYME; PRKCQ PROTEIN, MOUSE; PROTEIN KINASE C;

ADOPTIVE TRANSFER; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BONE MARROW; CELL SPECIFICITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG TARGETING; ENZYME ACTIVITY; ENZYME ANALYSIS; IMMUNOPATHOGENESIS; INFLAMMATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTOPOIESIS; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PATHOPHYSIOLOGY; T LYMPHOCYTE ACTIVATION; THYMUS; TOXIC HEPATITIS; WILD TYPE; ANIMAL; ANIMAL HEPATITIS; AUTOIMMUNE DISEASE; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; MOUSE MUTANT; PATHOLOGY;

MUS;

ANIMALS; AUTOIMMUNE DISEASES; CONCANAVALIN A; HEPATITIS, ANIMAL; INFLAMMATION; ISOENZYMES; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; NATURAL KILLER T-CELLS; PROTEIN KINASE C;

EID: 84863040855     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0031174     Document Type: Article

References (47)

1. McFarlane IG, (1999) Pathogenesis of autoimmune hepatitis. Biomed Pharmacother 53: 255-263.
2. Emoto M, Kaufmann SH, (2003) Liver NKT cells: an account of heterogeneity. Trends Immunol 24: 364-369.
3. Faggioni R, Jones-Carson J, Reed DA, Dinarello CA, Feingold KR, et al. (2000) Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity: role of tumor necrosis factor alpha and IL-18. Proc Natl Acad Sci U S A 97: 2367-2372.
4. Gantner F, Leist M, Lohse AW, Germann PG, Tiegs G, (1995) Concanavalin A-induced T-cell-mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 21: 190-198.
5. Leist M, Gantner F, Bohlinger I, Tiegs G, Germann PG, et al. (1995) Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 146: 1220-1234.
6. Gumperz JE, Brenner MB, (2001) CD1-specific T cells in microbial immunity. Curr Opin Immunol 13: 471-478.
7. Godfrey DI, Hammond KJ, Poulton LD, Smyth MJ, Baxter AG, (2000) NKT cells: facts, functions and fallacies. Immunol Today 21: 573-583.
8. Ishigami M, Nishimura H, Naiki Y, Yoshioka K, Kawano T, et al. (1999) The roles of intrahepatic Valpha14(+) NK1.1(+) T cells for liver injury induced by Salmonella infection in mice. Hepatology 29: 1799-1808.
9. Kaneko Y, Harada M, Kawano T, Yamashita M, Shibata Y, et al. (2000) Augmentation of Valpha14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J Exp Med 191: 105-114.
10. Kato A, Yoshidome H, Edwards MJ, Lentsch AB, (2000) Regulation of liver inflammatory injury by signal transducer and activator of transcription-6. Am J Pathol 157: 297-302.
11. Kawano T, Nakayama T, Kamada N, Kaneko Y, Harada M, et al. (1999) Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res 59: 5102-5105.
12. Kim CH, Butcher EC, Johnston B, (2002) Distinct subsets of human Valpha24-invariant NKT cells: cytokine responses and chemokine receptor expression. Trends Immunol 23: 516-519.
13. Tiegs G, Hentschel J, Wendel A, (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J Clin Invest 90: 196-203.
14. Bendelac A, (1995) Positive selection of mouse NK1+ T cells by CD1-expressing cortical thymocytes. J Exp Med 182: 2091-2096.
15. Bendelac A, Savage PB, Teyton L, (2007) The biology of NKT cells. Annu Rev Immunol 25: 297-336.
16. Crowe NY, Uldrich AP, Kyparissoudis K, Hammond KJ, Hayakawa Y, et al. (2003) Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J Immunol 171: 4020-4027.
17. Sivakumar V, Hammond KJ, Howells N, Pfeffer K, Weih F, (2003) Differential requirement for Rel/nuclear factor kappa B family members in natural killer T cell development. J Exp Med 197: 1613-1621.
18. Altman A, Isakov N, Baier G, (2000) Protein kinase Ctheta: a new essential superstar on the T-cell stage. Immunol Today 21: 567-573.
19. Pfeifhofer C, Kofler K, Gruber T, Tabrizi NG, Lutz C, et al. (2003) Protein kinase C theta affects Ca2+ mobilization and NFAT cell activation in primary mouse T cells. J Exp Med 197: 1525-1535.
20. Sun Z, Arendt CW, Ellmeier W, Schaeffer EM, Sunshine MJ, et al. (2000) PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytes. Nature 404: 402-407.
21. Weiss A, Littman DR, (1994) Signal transduction by lymphocyte antigen receptors. Cell 76: 263-274.
22. Baier-Bitterlich G, Uberall F, Bauer B, Fresser F, Wachter H, et al. (1996) Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol 16: 1842-1850.
23. Coudronniere N, Villalba M, Englund N, Altman A, (2000) NF-kappa B activation induced by T cell receptor/CD28 costimulation is mediated by protein kinase C-theta. Proc Natl Acad Sci U S A 97: 3394-3399.
24. Lin X, O'Mahony A, Mu Y, Geleziunas R, Greene WC, (2000) Protein kinase C-theta participates in NF-kappaB activation induced by CD3-CD28 costimulation through selective activation of IkappaB kinase beta. Mol Cell Biol 20: 2933-2940.
25. Li Y, Hu J, Vita R, Sun B, Tabata H, et al. (2004) SPAK kinase is a substrate and target of PKCtheta in T-cell receptor-induced AP-1 activation pathway. EMBO J 23: 1112-1122.
26. Baier G, (2003) The PKC gene module: molecular biosystematics to resolve its T cell functions. Immunol Rev 192: 64-79.
27. Kwon MJ, Wang R, Ma J, Sun Z, (2010) PKC-theta is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection. Endocr Metab Immune Disord Drug Targets 10: 367-372.
28. Fang X, Du P, Liu Y, Tang J, (2010) Efficient Isolation of Mouse Liver NKT Cells by Perfusion. PLoS ONE 5: e10288.
29. Spangrude GJ, (2008) Assessment of lymphocyte development in radiation bone marrow chimeras. Curr Protoc Immunol Chapter 4: Unit 4 6.
30. Watarai H, Nakagawa R, Omori-Miyake M, Dashtsoodol N, Taniguchi M, (2008) Methods for detection, isolation and culture of mouse and human invariant NKT cells. Nat Protocols 3: 70-78.
31. Nicoletti F, Zaccone P, Xiang M, Magro G, Di Mauro M, et al. (2000) Essential pathogenetic role for interferon (IFN-)gamma in concanavalin A-induced T cell-dependent hepatitis: exacerbation by exogenous IFN-gamma and prevention by IFN-gamma receptor-immunoglobulin fusion protein. Cytokine 12: 315-323.
32. van Deuren M, (1994) Kinetics of tumour necrosis factor-alpha, soluble tumour necrosis factor receptors, interleukin 1-beta and its receptor antagonist during serious infections. Eur J Clin Microbiol Infect Dis 13 (Suppl 1): S12-16.
33. Ramaiah SK, Rittling S, (2008) Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicol Sci 103: 4-13.
34. Savage AK, Constantinides MG, Han J, Picard D, Martin E, et al. (2008) The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29: 391-403.
35. Higuchi H, Grambihler A, Canbay A, Bronk SF, Gores GJ, (2004) Bile acids up-regulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun N-terminal kinase-dependent pathway involving Sp1. J Biol Chem 279: 51-60.
36. Malhi H, Barreyro FJ, Isomoto H, Bronk SF, Gores GJ, (2007) Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Gut 56: 1124-1131.
37. Exley MA, Koziel MJ, (2004) To be or not to be NKT: natural killer T cells in the liver. Hepatology 40: 1033-1040.
38. Mosyak L, Xu Z, Joseph-McCarthy D, Brooijmans N, Somers W, et al. (2007) Structure-based optimization of PKCtheta inhibitors. Biochem Soc Trans 35: 1027-1031.
39. Cywin CL, Dahmann G, Prokopowicz AS 3rd, Young ER, Magolda RL, et al. (2007) Discovery of potent and selective PKC-theta inhibitors. Bioorg Med Chem Lett 17: 225-230.
40. Stanic AK, Bezbradica JS, Park JJ, Van Kaer L, Boothby MR, et al. (2004) Cutting edge: the ontogeny and function of Va14Ja18 natural T lymphocytes require signal processing by protein kinase C theta and NF-kappa B. J Immunol 172: 4667-4671.
41. Schmidt-Supprian M, Tian J, Grant EP, Pasparakis M, Maehr R, et al. (2004) Differential dependence of CD4+CD25+ regulatory and natural killer-like T cells on signals leading to NF-kappaB activation. Proc Natl Acad Sci U S A 101: 4566-4571.
42. Manicassamy S, Gupta S, Sun Z, (2006) Selective function of PKC-theta in T cells. Cell Mol Immunol 3: 263-270.
43. Toyabe S, Seki S, Iiai T, Takeda K, Shirai K, et al. (1997) Requirement of IL-4 and liver NK1+ T cells for concanavalin A-induced hepatic injury in mice. J Immunol 159: 1537-1542.
44. Diao H, Kon S, Iwabuchi K, Kimura C, Morimoto J, et al. (2004) Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 21: 539-550.
45. Manicassamy S, Sun Z, (2007) The critical role of protein kinase C-theta in Fas/Fas ligand-mediated apoptosis. J Immunol 178: 312-319.
46. Czaja AJ, dos Santos RM, Porto A, Santrach PJ, Moore SB, (1998) Immune phenotype of chronic liver disease. Dig Dis Sci 43: 2149-2155.
47. Czaja AJ, Freese DK, (2002) Diagnosis and treatment of autoimmune hepatitis. Hepatology 36: 479-497.